BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7478542)

  • 1. Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors.
    Quang CT; Pironin M; von Lindern M; Beug H; Ghysdael J
    Oncogene; 1995 Oct; 11(7):1229-39. PubMed ID: 7478542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor.
    Wessely O; Bauer A; Quang CT; Deiner EM; von Lindern M; Mellitzer G; Steinlein P; Ghysdael J; Beug H
    Biol Chem; 1999 Feb; 380(2):187-202. PubMed ID: 10195426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-erb A oncogene causes repression of erythrocyte-specific genes and an immature, aberrant differentiation phenotype in normal erythroid progenitors.
    Schroeder C; Raynoschek C; Fuhrmann U; Damm K; Vennström B; Beug H
    Oncogene; 1990 Oct; 5(10):1445-53. PubMed ID: 1979159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
    Ehinger M; Bergh G; Johnsson E; Gullberg U; Olsson I
    Cell Growth Differ; 1997 Oct; 8(10):1127-37. PubMed ID: 9342191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
    von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
    Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenes and erythroid differentiation.
    Metz T
    Semin Cancer Biol; 1994 Apr; 5(2):125-35. PubMed ID: 8061329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
    Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
    Ehinger M; Nilsson E; Persson AM; Olsson I; Gullberg U
    Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibroblast growth factor receptor FGFR-4 acts as a ligand dependent modulator of erythroid cell proliferation.
    Koritschoner NP; Bartůnĕk P; Knespel S; Blendinger G; Zenke M
    Oncogene; 1999 Oct; 18(43):5904-14. PubMed ID: 10557077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
    Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
    Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPI-1 transforming properties depend upon specifically activated forms of the EPOR.
    Pereira R; Raingeaud J; Pironin M; Ghysdael J; Quang CT
    Oncogene; 2000 Oct; 19(44):5106-10. PubMed ID: 11042699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
    Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
    Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.